Shikonin inhibits the growth and N-acetylation of 2-aminofluorene in Helicobacter pylori from ulcer patients

Anticancer Res. 2004 May-Jun;24(3a):1587-92.

Abstract

N-acetyltransferase (NAT) plays an important role in the N-acetylation of arylamine carcinogens and drugs. Shikonin has been shown to induce apoptosis and inhibit angiogenesis in vivo and in vitro. In this study, shikonin elicited dose-dependent bacteriostatic activity in Helicobacter pylori cultures. Arylamine N-acetyltransferase (NAT) activity (N-acetylation of 2-aminofluorene) was determined in the Helicobacter pylori isolated from peptic ulcer patients. Bacterial cytosols or intact cells with or without specific concentrations of shikonin co-treatment showed different percentages of 2-aminofluorene acetylation. Shikonin also inhibited N-acetylation of 2-aminofluorene in these examined Helicobacter pylori cytosols and intact cells in a dose-dependent manner. The apparent values of Km and Vmax were decreased after co-treatment with 4 microM shikonin in the cytosol of Helicobacter pylori.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation / drug effects
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Arylamine N-Acetyltransferase / antagonists & inhibitors*
  • Arylamine N-Acetyltransferase / metabolism
  • Dose-Response Relationship, Drug
  • Fluorenes / metabolism*
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / enzymology
  • Helicobacter pylori / growth & development
  • Helicobacter pylori / metabolism
  • Humans
  • Kinetics
  • Naphthoquinones / pharmacology*
  • Peptic Ulcer / microbiology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Fluorenes
  • Naphthoquinones
  • 2-aminofluorene
  • shikonin
  • Arylamine N-Acetyltransferase